ICD10 code of Leukodystrophy and ICD9 code

Leukodystrophy is a group of rare, progressive genetic disorders affecting the white matter of the brain, and it does not have a single ICD-10 or ICD-9 code; instead, it is classified under various codes depending on the specific subtype, such as E75.2 for Metachromatic Leukodystrophy (ICD-10) or 330.0 (ICD-9). Because the term encompasses many distinct conditions, physicians must assign a code specific to the genetic diagnosis to ensure accurate medical billing and clinical tracking.

Why is there no single code for Leukodystrophy?

The term Leukodystrophy is an umbrella category for a diverse group of over 50 rare genetic disorders. These conditions are characterized by the degeneration of myelin, the protective sheath surrounding nerve fibers in the central nervous system. Because the underlying genetic mutations and clinical presentations vary significantly—from Krabbe disease to Pelizaeus-Merzbacher disease—the medical coding system (ICD) assigns unique codes to each specific form of Leukodystrophy rather than using a single, catch-all identifier. This specificity is essential for researchers at DiseaseMaps.org and clinical specialists to track patient outcomes and treatment efficacy accurately.

What are the common ICD-10 and ICD-9 codes used for Leukodystrophy?

When documenting a diagnosis of Leukodystrophy, medical professionals typically navigate the coding system based on the biochemical or genetic defect identified. Below are examples of how these conditions are categorized:

• Metachromatic Leukodystrophy: ICD-10: E75.24; ICD-9: 330.0


• Krabbe Disease (Globoid Cell Leukodystrophy): ICD-10: E75.23; ICD-9: 330.0


• Adrenoleukodystrophy: ICD-10: E71.520; ICD-9: 271.8


• Canavan Disease: ICD-10: E75.29; ICD-9: 330.0


• Alexander Disease: ICD-10: G31.89; ICD-9: 330.0

How is a diagnosis of Leukodystrophy confirmed?

Diagnosis of Leukodystrophy is a complex process that usually begins with clinical observation of neurological decline, followed by neuroimaging—typically an MRI—to visualize white matter abnormalities. A clinical geneticist will then order targeted gene panels or whole-exome sequencing to identify the specific mutation. For the 285 members of our Leukodystrophy community at DiseaseMaps.org, obtaining a precise genetic diagnosis is the critical first step toward accessing condition-specific care, clinical trials, and potential gene therapies.

Is genetic counseling recommended for families?

Yes, genetic counseling is vital for any family affected by Leukodystrophy. Because most forms are inherited in an autosomal recessive or X-linked pattern, understanding the recurrence risk is essential for family planning. A genetic counselor can help interpret the specific ICD-10 code associated with the family's diagnosis and explain the implications for siblings and extended family members, providing both clinical clarity and emotional support during the diagnostic journey.

Next steps

• Consult with a board-certified neurologist or metabolic specialist to confirm the exact subtype of Leukodystrophy.


• Request a copy of your genetic test report to ensure your medical records reflect the correct, specific ICD-10 coding.


• Join the Leukodystrophy community at DiseaseMaps.org to connect with others sharing similar diagnostic and treatment experiences.


• Contact the United Leukodystrophy Foundation for resources on specialized care centers and current clinical research.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• Orphanet: Rare Disease Database (orpha.net)


• NIH Genetic and Rare Diseases Information Center (GARD)


• OMIM (Online Mendelian Inheritance in Man)


• United Leukodystrophy Foundation (ulf.org)